Middle East And Africa Craniomaxillofacial Implants Market
Размер рынка в млрд долларов США
CAGR :
% 
 Прогнозируемый период |
2024 –2030 |
 Размер рынка (базовый год) |
|
 Размер рынка (прогнозируемый год) |
USD 96.81 |
 CAGR |
% |
| Основные игроки рынка |
>Рынок краниомаксиллофациальных имплантатов на Ближнем Востоке и в Африке по типу (заменитель костного трансплантата, имплантаты средней части лица, черепные/нейроимплантаты, нижнечелюстные ортогнатические имплантаты, система дистракции, системы фиксации черепного лоскута, система полной замены височно-нижнечелюстного сустава (ВНЧС), имплантаты, специфичные для пациента (PSI), продукты для восстановления твердой мозговой оболочки и другие), материал конструкции (металлы, заменитель костного трансплантата, полимеры/биоматериалы и другие), место применения (внешние фиксаторы и внутренние фиксаторы), тип хирургии ( реконструктивная хирургия , травматологическая хирургия, пластическая хирургия, ортогнатическая хирургия, стоматологическая хирургия, ЛОР-хирургия и другие), тип собственности (рассасывающиеся фиксаторы, нерассасывающиеся фиксаторы), конечный пользователь (больница, специализированные клиники, травматологические центры, амбулаторные хирургические центры) (ASC), прочие), канал сбыта (прямые тендеры и розничные продажи) - тенденции отрасли и прогноз до 2030 года.
Анализ и размер рынка краниомаксиллофациальных имплантатов на Ближнем Востоке и в Африке
Рынок краниомаксиллофациальных имплантатов на Ближнем Востоке и в Африке состоит из многих глобальных игроков, таких как Zimmer Biomet, Medtronic, DePuy Synthes и Stryker среди прочих. Присутствие этих компаний обеспечивает конкурентоспособные цены на краниомаксиллофациальные имплантаты по всему региону. Благодаря присутствию этих игроков на региональном и международном уровнях поставщики и производители предлагают продукцию с различными спецификациями и характеристиками для всех бюджетов. Рост распространенности врожденных деформаций лица является движущей силой роста рынка. Кроме того, ожидается, что рост числа случаев травм и дорожно-транспортных происшествий будет способствовать росту рынка.
Data Bridge Market Research анализирует, что рынок краниомаксиллофациальных имплантатов на Ближнем Востоке и в Африке, как ожидается, достигнет значения 96,81 млн долларов США к 2030 году, при среднегодовом темпе роста 5,4% в течение прогнозируемого периода. Этот рыночный отчет также подробно охватывает анализ цен и технологические достижения.
|
Отчет Метрика |
Подробности |
|
Прогнозируемый период |
2023-2030 |
|
Базовый год |
2022 |
|
Исторические годы |
2021 (Можно настроить на 2015 - 2020) |
|
Количественные единицы |
Доход в миллионах, объемы в единицах и цены в долларах США |
|
Охваченные сегменты |
Type (Bone Graft Substitute, Mid-Face Implants, Cranial/Neuro Implants, Mandibular Orthognathic Implants, Distraction System, Cranial Flap Fixation Systems, Total Temporomandibular (TMJ) Replacement System, Patient Specific Implants (PSI), Dural Repair Products, and Others), Material of Construction (Metals, Bone Graft Substitute, Polymers/Biomaterial, and Others), Application Site (External Fixators and Internal Fixators), Surgery Type (Reconstructive Surgery, Trauma Surgeries, Plastic Surgeries, Orthognathic Surgeries, Dental Surgeries, ENT Surgeries, and Others), Property Type (Resorbable Fixators, Non-Resorbable Fixators), End User (Hospital, Specialty Clinics, Trauma Centers, Ambulatory Surgical Centers (ASCs), Others), Distribution Channel (Direct Tender and Retail Sales) |
|
Countries Covered |
Saudi Arabia, South Africa, U.A.E., Egypt, Israel, Rest of Middle East and Africa |
|
Market Players Covered |
Zimmer Biomet (U.S.), Medtronic (U.S.), DePuy Synthes (U.S.), Stryker (U.S.), KLS Martin Group (U.S.), Jeil Medical Corp (South Korea), Anatomics Pty Ltd (Australia), Xilloc Medical Int B.V. (Netherlands), Teknimed (France), Bioplate Inc. (U.S.), Poriferous (U.S.), Innovasis, Inc.(U.S.), DIMEDA Instrumente GmbH (Germany) and Advin Healthcare (India) |
Market Definition
Craniomaxillofacial implants are employed for craniomaxillofacial surgeries. Craniomaxillofacial abnormalities occur during childbirth due to the mother's folic acid deficiency or genetic mutations. Facial defects also damage speech, eating, and language, and cause dental problems and hearing loss. It is generally performed to treat injuries, defects, and diseases in the head, neck, face, jaws, and hard and soft tissues of the oral and maxillofacial region. The increase in the geriatric population and the rise in the prevalence of bowel and bladder cancer are accelerating the growth of the market. Additionally, an adaptation of advanced technologies in the industry has stimulated market growth consequently. On the other hand, the growing demand for patients-specific implants in surgeries is likely to drive market growth in the projected period.
Middle East and Africa Craniomaxillofacial Implants Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
Rising prevalence rate of congenital facial deformities
Craniofacial deformities can range from small defects to disfiguring clefts and other malformations. Deformities can either be congenital (born with) or acquired through trauma, illness, or surgeries. Correcting these malformations requires the experience and expertise of reconstructive plastic surgeons and an entire craniofacial team.
Each patient’s situation and needs are unique. Most patients require multiple procedures performed over the course of several years. Moreover, increased cases of congenital facial deformities is expected to drive the growth of the Middle East and Africa craniomaxillofacial implants market.
For instance,
- The global registry and database on craniofacial anomalies, states that Congenital Anomalies (CA) are a major cause of infant mortality and childhood morbidity, affecting 2-3% of all babies. Approximately 1% of these newborns have syndromes or multiple anomalies. The study also estimated that 30% of cleft cases are syndromic and approximately 70% are non-syndromic.
According to the EarWell Center of Excellence, Craniofacial Deformities have more than 28 types of severe syndromes.
Therefore, rising prevalence of congenital facial deformities, is expected to drive the growth of the Middle East and Africa craniomaxillofacial implants market.
Increase in trauma cases and road accidents
Road accidents and trauma cases may cause brain damage and other complications, such as bruising, bleeding, and infection of the brain. These injuries can lead to loss of consciousness, confusion, memory lapses, and limb paralysis. These conditions can be either temporary or permanent, and surgery may be required. Road accident is one of the key causes of CMF injuries across the globe.
For instance,
- On June 21, 2021, WHO published a report that stated Approximately 1.3 million people die each year as a result of road traffic crashes. 93% of the world's fatalities on the roads occur in low- and middle-income countries, even though these countries have approximately 60% of the world's vehicles. Moreover, road traffic injuries are the leading cause of death for children and young adults aged 5-29 years.
- According to the South African Medical Research Council, trauma is responsible for over 60,000 deaths in South Africa each year. This includes deaths from road accidents, interpersonal violence, and other forms of trauma.
Moreover, sports injuries, which require craniomaxillofacial surgeries include injuries related to nasal bone, facial fracture, mandibular fracture, and others. Thus, rising cases of road accidents and trauma further drive the Middle East and Africa craniomaxillofacial implants market growth.
Opportunity
Rise in healthcare expenditure & infrastructure
Advancement in technologies and development in healthcare infrastructure is significantly impacting the market growth. Development in healthcare infrastructure is anticipated to provide better patient services during surgeries and establish a new healthcare delivery system. Advanced healthcare facility design and implementation of advanced technology is anticipated to accelerate the market growth
Development in healthcare infrastructure induces owing to factors, such as insurance penetration, affordability of the population, raising income, heightened average life span of the populace, encouraging medical tourism flow, and growing concern for cosmetic treatments among others.
Moreover, government bodies and healthcare organizations are supporting low and middle income countries to develop healthcare infrastructure.
For instance,
- The government of Zambia has been increasing its healthcare budget allocation in recent years to improve the quality of healthcare services and address the country's healthcare challenges. In 2021, the government allocated ZMW 8.7 billion to the health sector, an increase of 23% from the previous year.
- Zambia's healthcare expenditure has been steadily increasing over the years, from ZMW 3.1 billion in 2010 to ZMW 9.8 billion in 2019, according to data from the World Bank.
Restraint/Challenge
Lack of awareness in developing countries
People are highly unaware of craniomaxillofacial implants and the surgeries related to them. Countries that are underdeveloped or still in the developing stage show a lack of awareness about craniomaxillofacial implants. In addition, people are unaware of the reimbursement and the coverage they can get. Thus, many government organizations are taking part in spreading awareness about craniomaxillofacial implants through conferences and publishing research articles not just to the public but to medical practitioners as well.
For instance,
- In 2019, a study published in the Journal of Craniofacial Surgery found that there was a lack of awareness and knowledge about craniomaxillofacial surgery among healthcare professionals in sub-Saharan Africa. The study noted that this lack of awareness was leading to delays in diagnosis and treatment for patients with craniofacial deformities.
- In 2018, a report by the World Health Organization (WHO) noted that there was a shortage of skilled healthcare professionals, including surgeons, in many countries in the Middle East and Africa. This shortage was identified as a major barrier to improving access to specialized care, including craniomaxillofacial surgery.
Craniomaxillofacial implants have emerged as a widely accepted prosthetic treatment option. However, lack of public awareness and cost of the treatment act as barriers which is expected to limit the market growth.
Post-COVID-19 Impact on the Middle East and Africa Craniomaxillofacial Implants Market
COVID-19 created a negative impact on the Middle East and Africa craniomaxillofacial implants market. The lockdown restriction led to the emergence of various challenges such as decreased hospital visits and delays in treatment procedures.
The COVID-19 pandemic has impacted the market to an extent in negative manner. However, increasing government support and advancements in imaging techniques is expected to provide lucrative opportunities for market growth. Moreover, increasing partnerships, acquisitions, and collaboration among market players are expected to further fuel the market growth. Also, the growth was high since the market opened after COVID-19, and it is expected that there would be considerable growth in the sector. The market players are conducting multiple activities to improve surgical techniques for craniomaxillofacial implants. With this, the companies will bring advancement and innovation to the market.
Recent Developments
- In 2021, DePuy Synthes launched a new craniomaxillofacial implant system in Africa. The system features 3D-printed titanium plates and screws that are designed to provide better stability and reduce the risk of complications in complex cranial and facial reconstructions.
- In 2020, Maxillofacial Technologies, a South African medical technology company, launched a new line of craniomaxillofacial implants and instruments. The products include custom-made titanium implants that are designed to improve patient outcomes and reduce surgical time.
- In 2019, Medtronic launched a new titanium implant system for craniomaxillofacial surgery in the Middle East and Africa. The system features a range of implants and instruments designed to improve patient outcomes and reduce surgical time.
Middle East and Africa Craniomaxillofacial Implants Market Scope
Middle East and Africa craniomaxillofacial implants market is segmented into seven notable segments based on type, the material of construction, application site, surgery type, property type, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Bone Graft Substitute
- Mid-Face Implants
- Cranial/Neuro Implants
- Mandibular Orthognathic Implants
- Distraction System
- Cranial Flap Fixation Systems
- Total Temporomandibular (TMJ) Replacement System
- Patient Specific Implants (PSI)
- Dural Repair Products
- Others
Based on type, the market is segmented into bone graft substitute, mid-face implants, cranial/neuro implants, mandibular orthognathic implants, distraction system, cranial flap fixation systems, total temporomandibular (TMJ) replacement system, patient specific implants (PSI), dural repair products, and others.
Material of Construction
- Metals
- Bone Graft Substitute
- Polymers/Biomaterial
- Others
Based on material of construction, the market is segmented into metal, bone graft substitute, polymers/biomaterial, and others.
Application Site
- External Fixators
- Internal Fixators
Based on the application site, the market is segmented into external fixators and internal fixators.
Surgery Type
- Reconstructive Surgery
- Trauma Surgeries
- Пластические операции
- Ортогнатические операции
- Стоматологические кабинеты
- ЛОР-операции
- Другие
По типу хирургии рынок сегментирован на реконструктивную хирургию, травматологическую хирургию, пластическую хирургию, ортогнатическую хирургию, стоматологическую хирургию, ЛОР-хирургию и другие.
Тип недвижимости
- Рассасывающиеся фиксаторы
- Нерассасывающиеся фиксаторы
По типу свойств рынок сегментируется на рассасывающиеся и нерассасывающиеся фиксаторы.
Конечный пользователь
- Больница
- Специализированные клиники
- Травматологические центры
- Амбулаторные хирургические центры (ASC)
- Другие
В зависимости от конечного пользователя рынок сегментируется на больницы, специализированные клиники, травматологические центры, амбулаторные хирургические центры (АХЦ) и другие.
Канал распространения
- Прямой тендер
- Розничные продажи
По каналу сбыта рынок сегментируется на прямые поставки и розничные продажи.
Региональный анализ/информация о рынке краниомаксиллофациальных имплантатов на Ближнем Востоке и в Африке
Проведен анализ рынка краниомаксиллофациальных имплантатов на Ближнем Востоке и в Африке, а также предоставлены сведения о размерах рынка и тенденциях по странам, типу, материалу конструкции, месту применения, типу хирургического вмешательства, типу собственности, конечному пользователю и каналу сбыта, как указано выше.
Страны, охваченные этим рыночным отчетом: Южная Африка, Саудовская Аравия, ОАЭ, Египет, Израиль, остальной Ближний Восток и Африка. Саудовская Аравия доминирует на рынке с самой большой долей рынка. Эта доля объясняется присутствием ключевых игроков рынка, таких как Zimmer Biomet, Medtronic, DePuy Synthes и Stryker среди других. Ожидается, что растущая распространенность врожденных деформаций лица будет способствовать росту рынка в течение прогнозируемого периода в этом регионе.
Раздел отчета по странам также содержит отдельные факторы, влияющие на рынок, и изменения в регулировании рынка, которые влияют на текущие и будущие тенденции рынка. Такие данные, как анализ цепочки создания стоимости вверх и вниз по течению, технические тенденции, анализ пяти сил Портера и тематические исследования, являются некоторыми из указателей, используемых для прогнозирования рыночного сценария для отдельных стран. Кроме того, при предоставлении прогнозного анализа данных по странам учитываются наличие и доступность глобальных брендов и их проблемы, связанные с большой или малой конкуренцией со стороны местных и отечественных брендов, влияние внутренних тарифов и торговые пути.
Конкурентная среда и анализ доли рынка краниомаксиллофациальных имплантатов на Ближнем Востоке и в Африке
Конкурентная среда рынка краниомаксиллофациальных имплантатов Ближнего Востока и Африки содержит сведения о конкуренте. Включены сведения о компании, ее финансах, полученном доходе, рыночном потенциале, новых рыночных инициативах, глобальном присутствии, производственных площадках и объектах, производственных мощностях, сильных и слабых сторонах компании, запуске продукта, широте и широте продукта и доминировании в применении. Приведенные выше данные касаются только фокуса компаний на рынке.
Некоторые из основных игроков рынка краниомаксиллофациальных имплантатов на Ближнем Востоке и в Африке включают Zimmer Biomet (США), Medtronic (США), DePuy Synthes (США), Stryker (США), KLS Martin Group (США), Jeil Medical Corp (Южная Корея), Anatomics Pty Ltd (Австралия), Xilloc Medical Int BV (Нидерланды), Teknimed (Франция), Bioplate Inc. (США), Poriferous (США), Innovasis, Inc. (США), DIMEDA Instrumente GmbH (Германия) и Advin Healthcare (Индия) и другие.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Интерактивная панель анализа данных
- Панель анализа компании для возможностей с высоким потенциалом роста
- Доступ аналитика-исследователя для настройки и запросов
- Анализ конкурентов с помощью интерактивной панели
- Последние новости, обновления и анализ тенденций
- Используйте возможности сравнительного анализа для комплексного отслеживания конкурентов
Содержание
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET
1.4 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTERS FIVE FORCES MODEL
5 INDUSTRIAL INSIGHTS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING PREVALENCE RATE OF CONGENITAL FACIAL DEFORMITIES
6.1.2 INCREASE IN TRAUMA CASES AND ROAD ACCIDENTS
6.1.3 INCREASING DEMAND FOR FACIAL RECONSTRUCTION SURGERY
6.1.4 RECENT TECHNOLOGICAL ADVANCEMENTS IN CMF IMPLANTS
6.2 RESTRAINTS
6.2.1 HIGH COST OF SURGERIES AND IMPLANTS
6.2.2 IMPLANT MALFUNCTION AND ASSOCIATED RISK
6.2.3 LACK OF AWARENESS FOR CRANIOMAXILLOFACIAL SURGERY
6.3 OPPORTUNITIES
6.3.1 GROWING GERIATRIC POPULATION
6.3.2 RISE IN HEALTHCARE EXPENDITURE & INFRASTRUCTURE
6.3.3 GROWING R&D ACTIVITIES AND TECHNOLOGICAL ADVANCEMENT
6.3.4 INCREASE IN DEMAND FOR CUSTOMIZED AND PATIENT-SPECIFIC IMPLANTS
6.4 CHALLENGES
6.4.1 INCREASE IN PRODUCT RECALL
6.4.2 POST SURGERY COMPLIACTION
7 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE
7.1 OVERVIEW
7.2 BONE GRAFT SUBSTITUTE
7.2.1 NATURAL
7.2.2 SYNTHETIC
7.3 MID-FACE IMPLANTS
7.3.1 PLATES
7.3.2 SCREWS
7.4 CRANIAL/NEURO IMPLANTS
7.4.1 PLATES
7.4.2 SCREWS
7.4.3 CONTOURABLE MESHES
7.5 MANDIBULAR ORTHOGNATHIC IMPLANTS
7.5.1 PLATES
7.5.2 SCREWS
7.6 DISTRACTION SYSTEM
7.7 CRANIAL FLAP FIXATION SYSTEM
7.8 PATIENT SPECIFIC IMPLANTS (PSI)
7.8.1 METAL
7.8.2 PLASTIC
7.8.3 OTHERS
7.8.4 NORMAL
7.8.5 3D PRINTED
7.8.6 CAD
7.8.7 ADEPT SOFTWARE
7.8.8 CAM
7.8.9 OTHERS
7.9 TOTAL TEMPOROMANDIBULAR (TMJ) REPLACEMENT SYSTEM
7.1 DURAL REPAIR PRODUCTS
7.10.1 DURAL SEALANTS
7.10.2 DURAL SUBSTITUTES
7.11 OTHERS
8 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION
8.1 OVERVIEW
8.2 METALS
8.2.1 TITANIUM AND ALLOYS
8.2.2 STAINLESS STEEL
8.2.3 POLYETHERETHERKETONE (PEEK)
8.2.4 SILICON NITRIDE
8.2.5 OTHERS
8.3 BONE GRAFT SUBSTITUTE
8.4 POLYMERS/BIOMATERIAL
8.5 OTHERS
9 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE
9.1 OVERVIEW
9.2 INTERNAL FIXATORS
9.2.1 BONE GRAFT SUBSTITUTE
9.2.2 MID-FACE IMPLANTS
9.2.3 CRANIAL/NEURO IMPLANTS
9.2.4 MANDIBULAR ORTHOGNATHIC IMPLANTS
9.2.5 DISTRACTION SYSTEM
9.2.6 CRANIAL FLAP FIXATION SYSTEMS
9.2.7 TOTAL TEMPOROMANDIBULAR (TMJ) REPLACEMENT SYSTEMS
9.2.8 OTHERS
9.3 EXTERNAL FIXATORS
9.3.1 DISTRACTION SYSTEM
9.3.2 OTHERS
10 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE
10.1 OVERVIEW
10.2 RECONSTRUCTIVE SURGERY
10.2.1 BONE GRAFT SUBSTITUTE
10.2.2 MID-FACE IMPLANTS
10.2.3 CRANIAL/NEURO IMPLANTS
10.2.4 MANDIBULAR ORTHOGNATHIC IMPLANTS
10.2.5 DISTRACTION SYSTEM
10.2.6 CRANIAL FLAP FIXATION SYSTEMS
10.2.7 TOTAL TEMPOROMANDIBULAR (TMJ) REPLACEMENT SYSTEM
10.2.8 DURAL REPAIR PRODUCTS
10.2.9 OTHERS
10.3 TRAUMA SURGERIES
10.3.1 BONE GRAFT SUBSTITUTE
10.3.2 MID-FACE IMPLANTS
10.3.3 CRANIAL/NEURO IMPLANTS
10.3.4 MANDIBULAR ORTHOGNATHIC IMPLANTS
10.3.5 DISTRACTION SYSTEM
10.3.6 CRANIAL FLAP FIXATION SYSTEMS
10.3.7 TOTAL TEMPOROMANDIBULAR (TMJ) REPLACEMENT SYSTEM
10.3.8 DURAL REPAIR PRODUCTS
10.3.9 OTHERS
10.4 PLASTIC SURGERIES
10.4.1 MID-FACE IMPLANTS
10.4.2 MANDIBULAR ORTHOGNATHIC IMPLANTS
10.4.3 CRANIAL/NEURO IMPLANTS
10.4.4 DISTRACTION SYSTEM
10.4.5 CRANIAL FLAP FIXATION SYSTEMS
10.4.6 TOTAL TEMPOROMANDIBULAR (TMJ) REPLACEMENT SYSTEM
10.4.7 OTHERS
10.5 ORTHOGNATHIC SURGERIES
10.5.1 BONE GRAFT SUBSTITUTE
10.5.2 MANDIBULAR ORTHOGNATHIC IMPLANTS
10.5.3 DISTRACTION SYSTEM
10.5.4 TOTAL TEMPOROMANDIBULAR (TMJ) REPLACEMENT SYSTEM
10.5.5 OTHERS
10.6 DENTAL SURGERIES
10.6.1 DISTRACTION SYSTEM
10.6.2 OTHERS
10.7 ENT SURGERIES
10.7.1 BONE GRAFT SUBSTITUTE
10.7.2 MID-FACE IMPLANTS
10.7.3 OTHERS
10.8 OTHERS
11 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY PROPERTY TYPE
11.1 OVERVIEW
11.2 NON-RESORBABLE FIXATORS
11.3 RESORBABLE FIXATORS
12 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY END USER
12.1 OVERVIEW
12.2 HOSPITAL
12.3 SPECIALTY CLINICS
12.4 TRAUMA CENTERS
12.5 AMBULATORY SURGICAL CENTERS (ASCS)
12.6 OTHERS
13 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY DISTRIBUTION CHANNEL
13.1 OVERVIEW
13.2 DIRECT TENDER
13.3 RETAIL SALES
14 MIDDLE EAST AND AFRICA
14.1 SAUDI ARABIA
14.2 SOUTH AFRICA
14.3 U.A.E.
14.4 ISRAEL
14.5 EGYPT
14.6 REST OF MIDDLE EAST AND AFRICA
15 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: COMPANY LANDSCAPE
15.1 COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA
16 SWOT ANALYSIS
17 COMPANY PROFILE
17.1 ZIMMER BIOMET
17.1.1 COMPANY SNAPSHOT
17.1.2 REVENUE ANALYSIS
17.1.3 RODUCT PORTFOLIO
17.1.4 RECENT DEVELOPMENT
17.2 MEDTRONIC
17.2.1 COMPANY SNAPSHOT
17.2.2 REVENUE ANALYSIS
17.2.3 PRODUCT PORTFOLIO
17.2.4 RECENT DEVELOPMENT
17.3 DEPUY SYNTHES
17.3.1 COMPANY SNAPSHOT
17.3.2 REVENUE ANALYSIS
17.3.3 PRODUCT PORTFOLIO
17.3.4 RECENT DEVELOPMENT
17.4 STRYKER
17.4.1 COMPANY SNAPSHOT
17.4.2 REVENUE ANALYSIS
17.4.3 PRODUCT PORTFOLIO
17.4.4 RECENT DEVELOPMENTS
17.5 KLS-MARTIN GROUP
17.5.1 COMPANY SNAPSHOT
17.5.2 PRODUCT PORTFOLIO
17.5.3 RECENT DEVELOPMENT
17.6 ADVIN HEALTH CARE
17.6.1 COMPANY SNAPSHOT
17.6.2 PRODUCT PORTFOLIO
17.6.3 RECENT DEVELOPMENT
17.7 ANATOMICS PTY LTD.
17.7.1 COMPANY SNAPSHOT
17.7.2 PRODUCT PORTFOLIO
17.7.3 RECENT DEVELOPMENTS
17.8 BIOPLATE INC.
17.8.1 COMPANY SNAPSHOT
17.8.2 PRODUCT PORTFOLIO
17.8.3 RECENT DEVELOPMENT
17.9 DIMEDA INSTRUMENTE GMBH
17.9.1 COMPANY SNAPSHOT
17.9.2 PRODUCT PORTFOLIO
17.9.3 RECENT DEVELOPMENTS
17.1 INNOVASIS INC.
17.10.1 COMPANY SNAPSHOT
17.10.2 PRODUCT PORTFOLIO
17.10.3 RECENT DEVELOPMENT
17.11 JEIL MEDICAL CORPORATION
17.11.1 COMPANY SNAPSHOT
17.11.2 PRODUCT PORTFOLIO
17.11.3 RECENT DEVELOPMENT
17.12 PORIFEROUS
17.12.1 COMPANY SNAPSHOT
17.12.2 PRODUCT PORTFOLIO
17.12.3 RECENT DEVELOPMENT
17.12.4 MANUFACTURING CERTIFICATION
17.13 TEKNIMED
17.13.1 COMPANY SNAPSHOT
17.13.2 PRODUCT PORTFOLIO
17.13.3 RECENT DEVELOPMENT
17.13.4 MDSAP CERTIFICATION
17.14 XILLOC MEDICAL BV
17.14.1 COMPANY SNAPSHOT
17.14.2 PRODUCT PORTFOLIO
17.14.3 RECENT DEVELOPMENT
18 QUESTIONNAIRE
19 RELATED REPORTS
Список таблиц
TABLE 1 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 2 MIDDLE EAST AND AFRICA BONE GRAFT SUBSTITUTE IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 3 MIDDLE EAST AND AFRICA MID-FACE IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 4 MIDDLE EAST AND AFRICA CRANIAL/NEURO IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 5 MIDDLE EAST AND AFRICA MANDIBULAR ORTHOGNATHIC IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 6 MIDDLE EAST AND AFRICA PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL, 2021-2030 (USD MILLION)
TABLE 7 MIDDLE EAST AND AFRICA PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 8 MIDDLE EAST AND AFRICA PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SOFTWARE, 2021-2030 (USD MILLION)
TABLE 9 MIDDLE EAST AND AFRICA DURAL REPAIR PRODUCTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 10 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION, 2021-2030 (USD MILLION)
TABLE 11 MIDDLE EAST AND AFRICA METALS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION, 2021-2030 (USD MILLION)
TABLE 12 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 13 MIDDLE EAST AND AFRICA INTERNAL FIXATORS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 14 MIDDLE EAST AND AFRICA EXTERNAL FIXATORS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 15 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 16 MIDDLE EAST AND AFRICA RECONSTRUCTIVE SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 17 MIDDLE EAST AND AFRICA TRAUMA SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 18 MIDDLE EAST AND AFRICA PLASTIC SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 19 MIDDLE EAST AND AFRICA ORTHOGNATHIC SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 20 MIDDLE EAST AND AFRICA DENTAL SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 21 MIDDLE EAST AND AFRICA ENT SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 22 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY PROPERTY TYPE, 2021-2030 (USD MILLION)
TABLE 23 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 24 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 25 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY COUNTRY, 2021-2030 (USD MILLION)
TABLE 26 SAUDI ARABIA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 27 SAUDI ARABIA BONE GRAFT SUBSTITUTE IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 28 SAUDI ARABIA MID-FACE IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 29 SAUDI ARABIA CRANIAL/NEURO IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 30 SAUDI ARABIA MANDIBULAR ORTHOGNATHIC IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 31 SAUDI ARABIA DURAL REPAIR PRODUCTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 32 SAUDI ARABIA PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL, 2021-2030 (USD MILLION)
TABLE 33 SAUDI ARABIA PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 34 SAUDI ARABIA PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SOFTWARE, 2021-2030 (USD MILLION)
TABLE 35 SAUDI ARABIA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION, 2021-2030 (USD MILLION)
TABLE 36 SAUDI ARABIA METALS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION, 2021-2030 (USD MILLION)
TABLE 37 SAUDI ARABIA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 38 SAUDI ARABIA INTERNAL FIXATORS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 39 SAUDI ARABIA EXTERNAL FIXATORS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 40 SAUDI ARABIA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 41 SAUDI ARABIA RECONSTRUCTIVE SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 42 SAUDI ARABIA TRAUMA SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 43 SAUDI ARABIA PLASTIC SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 44 SAUDI ARABIA ORTHOGNATHIC SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 45 SAUDI ARABIA DENTAL SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 46 SAUDI ARABIA ENT SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 47 SAUDI ARABIA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY PROPERTY TYPE, 2021-2030 (USD MILLION)
TABLE 48 SAUDI ARABIA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 49 SAUDI ARABIA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 50 SOUTH AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 51 SOUTH AFRICA BONE GRAFT SUBSTITUTE IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 52 SOUTH AFRICA MID-FACE IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 53 SOUTH AFRICA CRANIAL/NEURO IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 54 SOUTH AFRICA MANDIBULAR ORTHOGNATHIC IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 55 SOUTH AFRICA DURAL REPAIR PRODUCTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 56 SOUTH AFRICA PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL, 2021-2030 (USD MILLION)
TABLE 57 SOUTH AFRICA PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 58 SOUTH AFRICA PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SOFTWARE, 2021-2030 (USD MILLION)
TABLE 59 SOUTH AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION, 2021-2030 (USD MILLION)
TABLE 60 SOUTH AFRICA METALS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION, 2021-2030 (USD MILLION)
TABLE 61 SOUTH AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 62 SOUTH AFRICA INTERNAL FIXATORS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 63 SOUTH AFRICA EXTERNAL FIXATORS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 64 SOUTH AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 65 SOUTH AFRICA RECONSTRUCTIVE SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 66 SOUTH AFRICA TRAUMA SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 67 SOUTH AFRICA PLASTIC SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 68 SOUTH AFRICA ORTHOGNATHIC SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 69 SOUTH AFRICA DENTAL SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 70 SOUTH AFRICA ENT SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 71 SOUTH AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY PROPERTY TYPE, 2021-2030 (USD MILLION)
TABLE 72 SOUTH AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 73 SOUTH AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 74 U.A.E. CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 75 U.A.E. BONE GRAFT SUBSTITUTE IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 76 U.A.E. MID-FACE IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 77 U.A.E. CRANIAL/NEURO IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 78 U.A.E. MANDIBULAR ORTHOGNATHIC IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 79 U.A.E. DURAL REPAIR PRODUCTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 80 U.A.E. PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL, 2021-2030 (USD MILLION)
TABLE 81 U.A.E. PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 82 U.A.E. PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SOFTWARE, 2021-2030 (USD MILLION)
TABLE 83 U.A.E. CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION, 2021-2030 (USD MILLION)
TABLE 84 U.A.E. METALS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION, 2021-2030 (USD MILLION)
TABLE 85 U.A.E. CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 86 U.A.E. INTERNAL FIXATORS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 87 U.A.E. EXTERNAL FIXATORS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 88 U.A.E. CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 89 U.A.E. RECONSTRUCTIVE SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 90 U.A.E. TRAUMA SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 91 U.A.E. PLASTIC SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 92 U.A.E. ORTHOGNATHIC SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 93 U.A.E. DENTAL SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 94 U.A.E. ENT SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 95 U.A.E. CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY PROPERTY TYPE, 2021-2030 (USD MILLION)
TABLE 96 U.A.E. CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 97 U.A.E. CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 98 ISRAEL CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 99 ISRAEL BONE GRAFT SUBSTITUTE IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 100 ISRAEL MID-FACE IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 101 ISRAEL CRANIAL/NEURO IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 102 ISRAEL MANDIBULAR ORTHOGNATHIC IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 103 ISRAEL DURAL REPAIR PRODUCTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 104 ISRAEL PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL, 2021-2030 (USD MILLION)
TABLE 105 ISRAEL PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 106 ISRAEL PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SOFTWARE, 2021-2030 (USD MILLION)
TABLE 107 ISRAEL CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION, 2021-2030 (USD MILLION)
TABLE 108 ISRAEL METALS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION, 2021-2030 (USD MILLION)
TABLE 109 ISRAEL CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 110 ISRAEL INTERNAL FIXATORS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 111 ISRAEL EXTERNAL FIXATORS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 112 ISRAEL CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 113 ISRAEL RECONSTRUCTIVE SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 114 ISRAEL TRAUMA SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 115 ISRAEL PLASTIC SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 116 ISRAEL ORTHOGNATHIC SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 117 ISRAEL DENTAL SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 118 ISRAEL ENT SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 119 ISRAEL CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY PROPERTY TYPE, 2021-2030 (USD MILLION)
TABLE 120 ISRAEL CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 121 ISRAEL CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 122 EGYPT CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 123 EGYPT BONE GRAFT SUBSTITUTE IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 124 EGYPT MID-FACE IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 125 EGYPT CRANIAL/NEURO IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 126 EGYPT MANDIBULAR ORTHOGNATHIC IMPLANTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 127 EGYPT DURAL REPAIR PRODUCTS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 128 EGYPT PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL, 2021-2030 (USD MILLION)
TABLE 129 EGYPT PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 130 EGYPT PATIENT SPECIFIC IMPLANTS (PSI) IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SOFTWARE, 2021-2030 (USD MILLION)
TABLE 131 EGYPT CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION, 2021-2030 (USD MILLION)
TABLE 132 EGYPT METALS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY MATERIAL OF CONSTRUCTION, 2021-2030 (USD MILLION)
TABLE 133 EGYPT CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 134 EGYPT INTERNAL FIXATORS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 135 EGYPT EXTERNAL FIXATORS IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY APPLICATION SITE, 2021-2030 (USD MILLION)
TABLE 136 EGYPT CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 137 EGYPT RECONSTRUCTIVE SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 138 EGYPT TRAUMA SURGERY IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 139 EGYPT PLASTIC SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 140 EGYPT ORTHOGNATHIC SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 141 EGYPT DENTAL SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 142 EGYPT ENT SURGERIES IN CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY SURGERY TYPE, 2021-2030 (USD MILLION)
TABLE 143 EGYPT CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY PROPERTY TYPE, 2021-2030 (USD MILLION)
TABLE 144 EGYPT CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 145 EGYPT CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
TABLE 146 REST OF MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY TYPE, 2021-2030 (USD MILLION)
Список рисунков
FIGURE 1 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: SEGMENTATION
FIGURE 2 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: DATA TRIANGULATION
FIGURE 3 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: DROC ANALYSIS
FIGURE 4 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS
FIGURE 5 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: SEGMENTATION
FIGURE 11 INCREASE IN DEMAND FOR PATIENTS SPECIFIC IMPLANTS ARE EXPECTED TO DRIVE THE MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 12 BONE GRAFT SUBSTITUTE IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET IN 2023 & 2030
FIGURE 13 DRIVER, RESTRAINTS, OPPORTUNITIES & CHALLENGES OF MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET
FIGURE 14 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY TYPE, 2022
FIGURE 15 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY TYPE, 2023-2030 (USD MILLION)
FIGURE 16 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY TYPE, CAGR (2023-2030)
FIGURE 17 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY TYPE, LIFELINE CURVE
FIGURE 18 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY MATERIAL OF CONSTRUCTION, 2022
FIGURE 19 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY MATERIAL OF CONSTRUCTION, 2023-2030 (USD MILLION)
FIGURE 20 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY MATERIAL OF CONSTRUCTION, CAGR (2023-2030)
FIGURE 21 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY MATERIAL OF CONSTRUCTION, LIFELINE CURVE
FIGURE 22 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY APPLICATION SITE, 2022
FIGURE 23 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY APPLICATION SITE, 2023-2030 (USD MILLION)
FIGURE 24 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY APPLICATION SITE, CAGR (2023-2030)
FIGURE 25 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY APPLICATION SITE, LIFELINE CURVE
FIGURE 26 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY SURGERY TYPE, 2022
FIGURE 27 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY SURGERY TYPE, 2023-2030 (USD MILLION)
FIGURE 28 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY SURGERY TYPE, CAGR (2023-2030)
FIGURE 29 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY SURGERY TYPE, LIFELINE CURVE
FIGURE 30 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY PROPERTY TYPE, 2022
FIGURE 31 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY PROPERTY TYPE, 2023-2030 (USD MILLION)
FIGURE 32 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY PROPERTY TYPE, CAGR (2023-2030)
FIGURE 33 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY PROPERTY TYPE, LIFELINE CURVE
FIGURE 34 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY END USER, 2022
FIGURE 35 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY END USER, 2023-2030 (USD MILLION)
FIGURE 36 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY END USER, CAGR (2023-2030)
FIGURE 37 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY END USER, LIFELINE CURVE
FIGURE 38 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 39 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY DISTRIBUTION CHANNEL, 2023-2030 (USD MILLION)
FIGURE 40 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2023-2030)
FIGURE 41 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 42 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: SNAPSHOT (2022)
FIGURE 43 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY COUNTRY (2022)
FIGURE 44 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 45 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: BY COUNTRY (2022 & 2030)
FIGURE 46 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: TEST TYPE (2023-2030)
FIGURE 47 MIDDLE EAST AND AFRICA CRANIOMAXILLOFACIAL IMPLANTS MARKET: COMPANY SHARE 2022 (%)
Методология исследования
Сбор данных и анализ базового года выполняются с использованием модулей сбора данных с большими размерами выборки. Этап включает получение рыночной информации или связанных данных из различных источников и стратегий. Он включает изучение и планирование всех данных, полученных из прошлого заранее. Он также охватывает изучение несоответствий информации, наблюдаемых в различных источниках информации. Рыночные данные анализируются и оцениваются с использованием статистических и последовательных моделей рынка. Кроме того, анализ доли рынка и анализ ключевых тенденций являются основными факторами успеха в отчете о рынке. Чтобы узнать больше, пожалуйста, запросите звонок аналитика или оставьте свой запрос.
Ключевой методологией исследования, используемой исследовательской группой DBMR, является триангуляция данных, которая включает в себя интеллектуальный анализ данных, анализ влияния переменных данных на рынок и первичную (отраслевую экспертную) проверку. Модели данных включают сетку позиционирования поставщиков, анализ временной линии рынка, обзор рынка и руководство, сетку позиционирования компании, патентный анализ, анализ цен, анализ доли рынка компании, стандарты измерения, глобальный и региональный анализ и анализ доли поставщика. Чтобы узнать больше о методологии исследования, отправьте запрос, чтобы поговорить с нашими отраслевыми экспертами.
Доступна настройка
Data Bridge Market Research является лидером в области передовых формативных исследований. Мы гордимся тем, что предоставляем нашим существующим и новым клиентам данные и анализ, которые соответствуют и подходят их целям. Отчет можно настроить, включив в него анализ ценовых тенденций целевых брендов, понимание рынка для дополнительных стран (запросите список стран), данные о результатах клинических испытаний, обзор литературы, обновленный анализ рынка и продуктовой базы. Анализ рынка целевых конкурентов можно проанализировать от анализа на основе технологий до стратегий портфеля рынка. Мы можем добавить столько конкурентов, о которых вам нужны данные в нужном вам формате и стиле данных. Наша команда аналитиков также может предоставить вам данные в сырых файлах Excel, сводных таблицах (книга фактов) или помочь вам в создании презентаций из наборов данных, доступных в отчете.
